Back
ESC Premium Access

Cardiotoxicity in haematological diseases: are the tyrosine kinase inhibitors imatinib and nilotinib safe?

Session: Poster session 7 - Chronic heart failure (CHF)
Topic: Cardiotoxicity of drugs
Speaker: Doctor A. Francisco (Lisbon, PT)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ana Francisco

Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre and Cardiovascular Centre , Lisbon (Portugal)
0 follower

29 more presentations in this session

Significance of non-thyroidal illness syndrome in patients with dilated cardiomyopathy

Speaker: Doctor M. Koga (Osaka, JP)

Access
Abstract
Like
Thumbnail

Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction

Speaker: Doctor P. Kanagala (Liverpool, GB)

Access
Abstract
Slides
Like
Thumbnail

Hematinic predictors of hemoglobin response to intravenous iron supplementation in chronic heart failure

Speaker: Associate Professor S. Caravita (Bergamo, IT)

Access
Abstract
Like
Thumbnail

The effect of anti-HER2 therapy in biventricular deformation mechanics.

Speaker: Doctor K. Keramida (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

The HER2 signaling network in human heart failure, implication for brest cancer treatment

Speaker: Professor P. Leszek (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 7 - Chronic heart failure (CHF)

Speakers: Doctor A. Francisco, Doctor M. Koga, Doctor P. Kanagala, Associate Professor S. Caravita, Doctor K. Keramida...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources